Evidence map›Paper›PMID 34582669›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

Human Papillomavirus (HPV) Prevalence and Type Distribution in Urban Areas of Malaysia.

Frhana Rahmat, Jo Yee Kuan, Z Hajiman, Nik Noorul Shakira Mohamed Shakrin, Nur Aishah Che Roos, Marami Mustapa, Nur Adnin Ahmad Zaidi, Azimah Ahmad

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Understanding exposomes and its relation with cancer risk in Malaysia based on epidemiological evidence: a narrative review.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Frhana RahmatFaculty of Medicine and Health Defence, Universiti Pertahanan Nasional Malaysia, 57000 Sungai Besi, Kuala Lumpur, Malaysia.
Jo Yee KuanGnosis Laboratory (M) Sdn Bhd., No 1, Jalan USJ 21/11, USJ 21, 47630 Subang Jaya, Selangor, Malaysia.
Z HajimanGnosis Laboratory (M) Sdn Bhd., No 1, Jalan USJ 21/11, USJ 21, 47630 Subang Jaya, Selangor, Malaysia.
Nik Noorul Shakira Mohamed ShakrinFaculty of Medicine and Health Defence, Universiti Pertahanan Nasional Malaysia, 57000 Sungai Besi, Kuala Lumpur, Malaysia.
Nur Aishah Che RoosFaculty of Medicine and Health Defence, Universiti Pertahanan Nasional Malaysia, 57000 Sungai Besi, Kuala Lumpur, Malaysia.
Marami MustapaFaculty of Medicine and Health Defence, Universiti Pertahanan Nasional Malaysia, 57000 Sungai Besi, Kuala Lumpur, Malaysia.
Nur Adnin Ahmad ZaidiFaculty of Medicine and Health Defence, Universiti Pertahanan Nasional Malaysia, 57000 Sungai Besi, Kuala Lumpur, Malaysia.
Azimah AhmadFaculty of Medicine and Health Defence, Universiti Pertahanan Nasional Malaysia, 57000 Sungai Besi, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is the third leading cause of death in Malaysia, and Human Papilloma Virus (HPV) is the principal aetiology that is responsible for its development. This study was aimed to determine the prevalence and distribution of HPV types among different age groups, ethnicity, and areas in Malaysia. MATERIALS AND

methodsA total of 764 women aged 20-74 years old within the cities of Johor Bahru, Kuala Lumpur, Ipoh, Penang, and Kota Kinabalu underwent both cervical cytological assessment and HPV DNA analysis. Cervical cytology glass slides were prepared using the liquid base technique (Path TEZT TM). HPV DNA was extracted using TANBead® Nucleic Acid Extraction Kit (Taiwan Advanced Nonotech Inc.), then the types were further identified using a DR.HPV Genotyping IVD kit.

resultsThe prevalence of HPV infection was 14.0% (107/764) with high-risk type at 10.7% (82/764) and low-risk type at 3.27% (25/764). The most common high-risk HPV types were HPV-52, 66, 33, 39, and 58 whereas low-risk HPV types were HPV-6, 40, and 81. The majority of HPV infections (80.37%) were detected in women with normal cytology results. The most prevalent HPV type among Chinese is 33 (n=6) followed by 16, 44, 58, 66 and 68 (n=5). Among Malays, HPV 16 and 51 were the two most prevalent types (n=2). The sensitivity of the HPV DNA test compared to cytology was 100% with a specificity of 88.37%.

conclusionThis study revealed that the most common high-risk HPV type among women living in urban areas in Malaysia is HPV 52, unfortunately which is not the type of infection the current HPV vaccine is covered for protection among females. These findings may contribute beneficial information to health care providers for the appropriate use of HPV vaccine in the prevention of cervical cancer in Malaysia.

Indexed as

AdultAgedFemaleHumansMalaysiaMiddle AgedPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesPrevalenceUrban HealthYoung AdultPapillomavirus VaccinesCervical cancerHPV 52human papillomavirusPrevalenceVaccination

Identifiers

PMID34582669
PMCPMC8850893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.